This inventor holds 1 USPTO granted patent. Top assignee: Yasutoshi Muto. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Eiichi Tomita: Innovator in Anticarcinogenic Drug Composition
Introduction
Eiichi Tomita is a notable inventor based in Gifu, Japan. He has made significant contributions to the field of medicine, particularly in the development of anticarcinogenic drug compositions. His work focuses on addressing critical health issues related to various types of cancer.
Latest Patents
Eiichi Tomita holds a patent for an anticarcinogenic drug composition. This invention effectively inhibits the recurrence of hepatocellular carcinoma and reduces the occurrence of other cancers, including cervical carcinoma intraepitheliale, lung adenocarcinoma, and mammary tumors. The composition is highly safe and contains 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid or a salt thereof. He has 1 patent to his name.
Career Highlights
Throughout his career, Tomita has been dedicated to advancing cancer treatment options. His innovative approach to drug composition has the potential to significantly improve patient outcomes in high-risk groups. His work exemplifies the intersection of research and practical application in the medical field.
Collaborations
Eiichi Tomita has collaborated with notable colleagues, including Yasutoshi Muto and Hisataka Moriwaki. These partnerships have contributed to the development and refinement of his innovative drug compositions.
Conclusion
Eiichi Tomita's contributions to the field of anticarcinogenic drug development highlight his commitment to improving cancer treatment. His innovative work continues to inspire advancements in medical research and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile